Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 53 clinical trials
Pro-thrombotic Status in Patients With SARS-Cov-2 Infection (ATTAC-Co)

The present study is ideated to prospectively investigate in patients with severe acute respiratory syndrome (SARS) due to Coronavirus 19 (SARS-Cov-2) infection and moderate-severe respiratory failure the patterns and changes in platelet reactivity, thrombotic status and endothelial function. The observed patterns and changes will be related with inflammatory status, myocardial …

FIO2
SARS
respiratory failure
pao2
mechanical ventilation
  • 0 views
  • 04 Mar, 2022
  • 1 location
An Open-Label Study of Apabetalone in Covid Infection

The primary objective of the study is to evaluate the safety and effect on clinical course of oral apabetalone in hospitalized subjects with Covid-19 infection

  • 4 views
  • 22 Mar, 2022
  • 1 location
Trial With or Without Infusion of SARS-CoV-2 Antibody Containing Plasma in High-Risk Patients With COVID-19 (RECOVER)

The study RECOVER is a randomized, open-label, multicenter phase II trial, designed to assess the clinical outcome of SARS-CoV-2 disease in high-risk patients (group 1 to group 4) following treatment with anti-SARS-CoV-2 convalescent/vaccine-boosted plasma or standard of care.

  • 0 views
  • 25 Mar, 2022
  • 1 location
Safety, Tolerability and Efficacy of Uproleselan (GMI-1271) in Patients With COVID-19 Pneumonia

The purpose of this study is to find out whether the drug uproleselan can help patients with severe COVID-19 pneumonia. Investigators will study both the side effects of the drug and assess if the drug will help patients recover more quickly and slow down the progression of acute respiratory failure.

  • 0 views
  • 15 Dec, 2021
  • 1 location
Clinical Experimentation With Tenofovir Disoproxyl Fumarate and Emtricitabine for COVID-19

Clinical, control, double-blind, randomized trial with tenofovir disoproxyl fumarate and emtricitabine for Covid-19

  • 0 views
  • 01 Feb, 2021
  • 1 location
MK-7075 (Miransertib) in Proteus Syndrome

Background Proteus syndrome is a rare overgrowth disorder. Most people begin to have symptoms between 6 months and 2 years of age. There are very few living adults with this disease. There is also no known treatment for it. Researchers want to see if a new drug can slow down …

  • 0 views
  • 16 May, 2022
  • 1 location
A Performance Evaluation of the LumiraDx Point Of Care D-dimer Assay (EMBOL1)

In patients with symptoms of Venous Thromboembolism (VTE) (mainly deep vein thrombosis (DVT) or pulmonary embolism (PE)), the study will evaluate the agreement between the D-Dimer measurements

clot
dvts
thrombosis
thromboembolism
embolism
  • 2 views
  • 23 Mar, 2022
  • 9 locations
Apixaban for Extended Anticoagulation (APIDULCIS) (APIDULCIS)

) (VTE). Patients at high risk of recurrence (with altered D-dimer test), who had received anticoagulation (whatever the drug used) for 12-15 months after the first episode of thrombosis, will be treated

clot
apixaban 2.5 mg
thrombosis
deep vein thrombosis
anticoagulation therapy
  • 14 views
  • 14 Feb, 2022
  • 1 location
Evaluation of the LumiraDx Point of Care D-Dimer and CRP Tests (NOVEL-3)

A Multicenter Study Conducted to Evaluate the Agreement between Fingerstick Whole Blood, Venous Whole Blood and Plasma Determined on the LumiraDx Point of Care D-Dimer and Point of Care CRP

Accepts healthy volunteers
hypertension
diabetes
  • 28 views
  • 19 Apr, 2022
  • 4 locations
Evaluation of Clinical and Antibody Response to Covid-19 Vaccination Strategy in TBRI Egypt

Evaluation of the efficacy of the AstrazenicaCovid 19 vaccine to develop IgG antibody and its level based on th12 weeks program. Also to follow the changes of markers of coagulation (D-dimer

  • 18 views
  • 11 Sep, 2021
  • 1 location